Ekso Bionics Holdings, Inc. (EKSO)
10.66
+0.66
(+6.60%)
USD |
NASDAQ |
Mar 04, 16:00
10.80
+0.14
(+1.31%)
Pre-Market: 20:00
Ekso Bionics Holdings Cash from Investing (Quarterly) : -0.126M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -34.91M |
| Autonomix Medical, Inc. | -0.007M |
| Abbott Laboratories | -913.00M |
| Accuray, Inc. | -5.596M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.331M |
| Cash from Financing (Quarterly) | 2.921M |
| Free Cash Flow | -11.99M |
| Free Cash Flow Per Share (Quarterly) | -1.495 |
| Free Cash Flow to Equity (Quarterly) | -4.146M |
| Free Cash Flow to Firm (Quarterly) | -4.302M |
| Free Cash Flow Yield | -13.56% |